FibroGen Soars 13%: Investors Bet On Promising Drug Trial Results
(VIANEWS) – On Friday, FibroGen’s Stock Gains 13.12% and NASDAQ Closes Up 0.31% FibroGen (NASDAQ: FGEN) saw its stock surge 13.12% to EUR0.62 at 21:24 EST on Friday after three consecutive sessions of gains, an unexpected turnaround from its recent losses and continued ascent higher. Meanwhile, the NASDAQ index gained 0.31% and reached EUR14,270.62 after…